肝臓病教室201207v2配布用.pptx

Save this PDF as:
 WORD  PNG  TXT  JPG

Size: px
Start display at page:

Download "肝臓病教室201207v2配布用.pptx"

Transcription

1 C C C C 11 1 vs 2 vs 1

2 mg 3-5/ 24, mg 6-9/ () mg 3-5/ % C ALT, GPT % ALT, GPT

3 , % /16 10 A B C D E F G ( ) 14 3

4 IFN IFNALT 4

5 CT MRI C 5 C, C C / 5

6 DVD 6

Microsoft Word - 表紙資料2-4

Microsoft Word - 表紙資料2-4 (1) / 130 g 25 g 520% 170 g 30 g 560% 70 mg 600 mg 11.6% 0 10.5 mg 0% (1) (2) / 50100 g 25 g 200400% 50100 g 30 g 167333% 5001000 mg 600 mg 83167% 1020 mg 10.5 mg 95190% (2) / (1) 45.6 g 30 g 152% (2)

More information

104 100 60 9,195,336 409 0.004 24 8 31 9,025,983 568 0.006 2012 8 31 6,634,686 956 ( 0.014 ) 2 2011 8 26

104 100 60 9,195,336 409 0.004 24 8 31 9,025,983 568 0.006 2012 8 31 6,634,686 956 ( 0.014 ) 2 2011 8 26 25 25 3 5 MMR 1 104 100 60 9,195,336 409 0.004 24 8 31 9,025,983 568 0.006 2012 8 31 6,634,686 956 ( 0.014 ) 2 2011 8 26 2012 8 31 1,032,660 132 ( 0.013 ) 3 2010 6 11 3 11 15.4 1 1 ( ) 12 2 2 3 ER ) (

More information

橡アロマセラピー症状別処方例.PDF

橡アロマセラピー症状別処方例.PDF 1 1 92 E 100ml 1 2 2 1 93 0.5m 10ml 100ml 1 2 3 2 52 0. l 2 4 3 27 3 1 1 3 3 4 5 3 2g 2 3 1 1 1 10ml 3 4 6 3 29 2 2 2 10ml 3 3 4 7 3 30 2 1 2 10ml 3 3 4 8 3 31 1 1 1 1 3 60 10 10 3 2 4 10ml A 2 3 61 20

More information

A 01 2 015 10 11 12 G 011 2 0111 67

A 01 2 015 10 11 12 G 011 2 0111 67 66 A 01 2 015 10 11 12 G 011 2 0111 67 0119 0112 0113 68 0130 0128 0114 0113 0115 0116 0119 69 0111 0128 012 2 0121 1102 0122 0123 0124 70 0125 0126 0126 0111 0127 71 0128 0129 0230 013 0130 0130 011 012

More information

次世代育成支援行動計画

次世代育成支援行動計画 15 7 10 300 9 17 21 5 21 22 5 1 2 3 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 16 39 40 11 2 3 P P 41 42 13 3 70.4 86.0 33.3 35.1 75.3 91.5 28.8 36.2 49.0 28.7 14.0 10.0

More information

00 0 0 0 0 0 00 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.... 0........ 0 0 0 0 0 0 0 0 0 0..0..........0 0 0 0 0 0 0 0 0 0 0.... 0........ 0 0 0 0 0 0 0 0 0 0... 0...... 0... 0 0 0 0 0 0..0 0... 0 0 0 0 0.0.....0.

More information

Microsoft Word - 倫理 第40,43,45,46講 テキスト.docx

Microsoft Word - 倫理 第40,43,45,46講 テキスト.docx 6 538 ( 552 ) (1) () (2) () ( )( ) 1 vs () (1) (2) () () () ) ()() (3) () ( () 2 () () () ()( ) () (7) (8) () 3 4 5 abc b c 6 a (a) b b ()() 7 c (c) ()() 8 9 10 () 1 ()()() 2 () 3 1 1052 1051 () 1053 11

More information

14 12 10 8 6 4 2 0 1 2 3 4 5 6 7 8 9 10 11 12 20 0 0 0 0 0 0 0 0 0 0 0 0 21 0 0 0 0 0 0 0 0 0 0 0 0 22 0 0 0 0 0 0 0 0 0 0 0 0 23 0 0 0 0 0 0 0 0 0 0 0 0 24 0 0 0 0 0 0 0 0 0 0 0 0 25 0 0 0 0 0 0 0 0 0

More information

untitled

untitled 9 8 29 () 9 8 29 () 9 11 30 () 10 2 14 () 3 10 7 24 () 10 10 9 () 10 8 2 10 11 14 () 10 12 25 () 40 50 100 1953 11 2 26 11 11 3 29 11 6 10 11 1 12 15 2 3 12 12 10 6 12 4 8 5 55 60 100 100 2 25 15 7 29

More information

untitled

untitled NO.39 NO.39 ---------------------------------------------------------------------- http://clickanketo.com/cgi-bin/a.cgi?q00006480a20-1- -2- -3- http://clickanketo.com/cgi-bin/a.cgi?q00006577a01 http://clickanketo.com/cgi-bin/a.cgi?q00006577a72

More information

<836C83628367834A8374834692B2B895F18145706466>

<836C83628367834A8374834692B2B895F18145706466> 1. 30 5 500 2 7 100 2 10 100 2007 4 1 7,200 6,800 7 NPO 1,200 1 12 15 2 1.5 0.5 30 2 24 5 27 16.8 28 2.3 10,500 / 3 3,800 117 2 3 6 6,000 1 1 1 2 2006 1 6, 000 + + 8 30 17 00 7.5 13 2 B2 2. 50 2 3 1 1

More information

Proposal Template

Proposal Template 74 2 3 33.5 33.5 13.0 13.0 16.5 16.5 11.0 11.0 10.5 10.5 10.5 10.5 0.5 0.5 3.5 3.5 1.0 1.0 35.0 (180n) 90 65.0 40.0 (20n) 10 60.0 4 5 20 20 24 24 0 25 25 29 29 20.0 20.0 30 30 34 34 20.0 20.0 35 35 39

More information

,000 1,000 1,000 1,000 1,000 1,000 1,000 1,000 1,

,000 1,000 1,000 1,000 1,000 1,000 1,000 1,000 1, 1 1 1 2 1 3 1 4 2 5 5 6 6 1 6 2 7 3 7 4 7 5 7 7 8 8 10 1 10 2 10 3 10 12 1 12 2 12 3 12 4 13 5 14 14 1 14 1 2 3 4 5 1 2 3 4 16 5 16 6 16 7 17 6 17 18 19~23-19- 1 0.5 1 43.25 2.20 3.60 103.50 43.88 2.20

More information

平成22年度

平成22年度 ( 2 4 9 (4 11 ) H26.3 5 6 + 7 8 25 24 1 1 184 22 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 24 10 9 29 24 12 27 23 1 11 6 4 6 9 3 1 1 1 2

More information

8 8 0

8 8 0 ,07,,08, 8 8 0 7 8 7 8 0 0 km 7 80. 78. 00 0 8 70 8 0 8 0 8 7 8 0 0 7 0 0 7 8 0 00 0 0 7 8 7 0 0 8 0 8 7 7 7 0 j 8 80 j 7 8 8 0 0 0 8 8 8 7 0 7 7 0 8 7 7 8 7 7 80 77 7 0 0 0 7 7 0 0 0 7 0 7 8 0 8 8 7

More information

untitled

untitled 27 DVD P2 P10 P3 P10 P3 P1113 P310 P14-1 - 27 DVDDVD DVD DVD - 2 - 27-3 - 27-4 - 27-5 - 27-6 - 27-7 - 27-8 - 27-9 - 27 6/25 7/9 7/198/2 7/318/4 8/14 8/21 8/27 9/11 9/1719-10 - 27-11 - 27-12 - 27-13 - 27-14

More information

indb

indb 2010 203 1. 1 2010 p. 15 204 2 2. 1 50 2007 4 2 1 18 20 2007 205 1 3 2 1950 2007 1955 p. 28 SF 2007 2 4 3 73 2007 1 SEX 206 2007 72 3 5 4 77 3 J 1989 J WAVE 2005a J J 1983 1979 6 5 2007 4 93 80 4 5 207

More information

comment_site3

comment_site3 VS 1 2 3 4 5 6 2013 03 12 7 JK 8 1992 2012 2011 3 11 311 9 10 311 DVD Face Book 11 Face Book (3/2) 1970 1980 12 ( ) ) 13 compassion= compassion= Face Book 3.11 Face Book 14 3.11 Face Book 15 16 w Face

More information

H28.4 / 11 28 7 1 28 28 1 27 29 30 4 1 29 5 5 2 2 1 2 2 28 3 1 28 http://www.city.saitama.jp/005/001/018/003/p036471.html 2 28 7 11 28 8 31 3 CD DVD 4 4 5 7 11 8 31 9 1 9 30 10 1 10 31 11 1 11

More information

レイアウト 1

レイアウト 1 1 3 6 7 8 3 6 7 8 g mg 6 1 16 16 18 16 13 138 13 16 1 11 8 78 8 17 9 9 g mg 18 13 1 1 1 99 6 3 36 3 3 8 1 18 18 18 16 16 1 1 g mg 1 1 13 13 1 11 11 g mg 8 6 g 1 g mg 93 38 9 93 8 8 176 1 1 1 1 11 18

More information

17高度化-8 中山間地域活性化のための機械化・情報化推進可能性調査報告書

17高度化-8 中山間地域活性化のための機械化・情報化推進可能性調査報告書 14 24 34 44 2000 9 1974 1980 1985 1987 1989 1990 1993 10 1990 1993 2000 2.2-1 2 7001,000 ppm LPG pec MRI 3030 30 ECpH PHS 100m 7 15 70cm JFE 28 1 4,800 1 8000 2000 2001 60 3030

More information

untitled

untitled 1 2 DVD DVD 3 4 DVD 5 6 7 8 9 ILLUMINTIchair 10 11 http://response.jp/issue/2005/1210/article77281_1.html http://www.bs4.jp/tbl/sp/index_02.html http://www3.nhk.or.jp/toppage/navi/documentary.html 100

More information

[ml] 180 160 140 120 100 80 60 40 20 0 Cumulative biogas production [ml/mg-input VS] 0 10 20 30 40 50 60 [] 1 0.8 0.6 0.4 0.2 0 dog food PLA foam 0 10 20 30 40 50 days RUN1-1 RUN1-2 RUN2-1 RUN2-2 RUN3-1

More information

NIHSS score p NIHSS score p149 4 p g ml 0.8 g ml D 1 D NIH NIHSS 14 D 0.8 g ml

NIHSS score p NIHSS score p149 4 p g ml 0.8 g ml D 1 D NIH NIHSS 14 D 0.8 g ml NIHSS score14 1 400 1 p149 1 25 20 NIHSS score14 15 10 5 2 p149 4 p151 0 0.8 g ml 0.8 g ml D 1 D NIH NIHSS 14 D 0.8 g ml 1 2 148 149 3 2 3 A B C 4 D 2 A B C A C 1 Ogata T et al J Neurol Sci 272 83 86 2008

More information

2014 26 10 18 9301000 925 927 930 31 33 36 39 42 45 48 50 53 14 20 11 8 13 3 14 12 34 22 20 8 0 49 12 12 28 23 12 22 11 7 6 26 2 4 27 5 6 2 8 10 0 45 17 1 12 10 0 2 19 12 8 10 6 6 10 18 4

More information

152273335 1 123 11531 2 5 24 31 2 154301482 1551 JAS 100 2000 105 1101 1 2JAS 1-2 1

152273335 1 123 11531 2 5 24 31 2 154301482 1551 JAS 100 2000 105 1101 1 2JAS 1-2 1 152273335 1 123 11531 2 5 24 31 2 154301482 1551 JAS 100 2000 105 1101 1 2JAS 1-2 1 JAS 1-2 1-2 112 13 1-11-13 100870mg 100830mg11000 1100020.002 2 50 100 2 100 500 2 100 109252165 4514782 7 2.0kg 2-19220.05kg0.2kg

More information

Digital Photo Professional Ver1.6(Windows)

Digital Photo Professional Ver1.6(Windows) Windows CT1-5193-000 CANON INC. 2005 J 1 2 3 4 s s s 1 1 s s s s s 1 1 a s s 1 s s 1 2 s a 1 s a 2 3 1 1 s a a 2 a 3 a s s 1 a a s a s s 1 s s 1 2 3 s 1 1 a 2 a 1 a s 2 3 1 1 s a 2 1 3 1 s a 2

More information

事業報告書

事業報告書 22 23 202,803 144,683 58,120 120,411 117,455 2,956 59.6 81.3 21.7% 22 23 62,677 56,001 6,676 57,734 61,454 3,720 120,411 117,455 2,956 47,092 13,255 33,837 19,397 7,666 11,731 3,546 401 3,145 3,290 1,546

More information

2001 11 14 19971219947 2 13 4 1 1 1 1 200 1000 1 1 00 2 3 30 100 3 5000 5 1 100 1 100 4 5 6 1 26,234 12,084 9,142 26,916 7 , 1 1 4 8 3 9 100 1895 3516870 100 10 11 W 14 15 New 16 W 11 14 21 1 W 63

More information

1 MR 63 2 IF 10 3 IF 2 IF IF IF 3 IF A4 9 IF IF IF 11 1 IF IF 4 IF IF MR IF IF MR Drug Safety Update IF

1 MR 63 2 IF 10 3 IF 2 IF IF IF 3 IF A4 9 IF IF IF 11 1 IF IF 4 IF IF MR IF IF MR Drug Safety Update IF 2003 7 3 872189 873919 IF 1998 9 PROBEAN CAP. 1 250mg Polyenephosphatidylcholine 1998 9 16 1999 7 9 1999 7 FAX IF 2003 7 1 MR 63 2 IF 10 3 IF 2 IF IF IF 3 IF A4 9 IF IF IF 11 1 IF IF 4 IF IF MR IF IF MR

More information

EL-G37

EL-G37 EL-G37 A A A A A A A A A A A A A A GT F543210A CE CA 4 00. 00 23.80 2 015.6250 77.14286 96. 91. 102. 25. 9. 1 700. 2 720. 2.5 7. 20. 25. 220. 400. 4 096. 4.685 0.084 M 125. M 28. M 85.

More information

平成17年度 奈良公立学校優秀教職員表彰実践事例集

平成17年度 奈良公立学校優秀教職員表彰実践事例集 17 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 3 ALT δ δ δ δ δ δ ( ) 24 E-mailnarahs@oak.ocn.ne.jp 17

More information

がん診療におけるFDG FDG-PET/CTの役割

がん診療におけるFDG FDG-PET/CTの役割 PET/CT PET/CT MRI PET PET/CT Kurashiki Central Hospital FDG-PET CT PET/CT (stage1) FDG-PET (stage1) PET/CT FDG-PET PET/CT (stage4) FDG-PET (stage4) PET/CT FDG-PET PET/CT PET/CT

More information

untitled

untitled 1.4 特 許 状 況 - 1 - - 2 - 1.5 起 原 又 は 発 見 の 経 緯 及 び 開 発 の 経 緯 FCT CT RH ... 1.5-1... 1.5-1... 1.5-1... 1.5-1... 1.5-2... 1.5-2... 1.5-2... 1.5-3...1.5-4... 1.5-5 i 10mg FCT 1 1 6 15 5mg CT 1 1 2 6 4mg CT

More information

マニュアル第4版表紙PDF

マニュアル第4版表紙PDF 5 2004 4 1 5 2004 1968 1993 1994 1996 1998 2001 2004 3 I 1 1 2 2 3 12 4 24 5 48 6 59 7 65 8. 68 9 72 10 76 11 80 12 82 13 84 14 88 15 98 16. 106 17. (AIDS) 108 18 113 19 117 20 119 21 TPN 122 22 125 23.

More information

「若年不安定就労・不安定住居者聞取り調査」報告書

「若年不安定就労・不安定住居者聞取り調査」報告書 2008 3 2006 2007 3 19 6 7 5,400 2007 4 5 19 94 1 2 2007 5 i 2007 6 12 100 100 1 2 2008 3 ii 1960 1990 iii = 1990 = = iv 5 5 v & = 2 24 = 1990 10 vi vii i iii 1 3 1.1.............................................

More information

(1) (2) (3) (1) (2) (3) (1) (2) (3) (4) (1) (2)

(1) (2) (3) (1) (2) (3) (1) (2) (3) (4) (1) (2) (1) (2) (3) (1) (2) (3) (1) (2) (3) (4) (1) (2) (1) (2) (3) (1) (2) (3) (1) (2) (3) vs. (2) (1) 16 22 143,977 24,030 55,769 600 (2) (3) (4) (1) (2) (1) (2) 2 (3) (abuse) (1) (2) (3) (1) (2) (3)

More information

01_表紙

01_表紙 2012.1.10 8 Hijicho http://hijicho.comhttp://twitter.com/hijicho/ Hijicho http://hijicho.comhttp://twitter.com/hijicho/ () () Hijicho http://hijicho.comhttp://twitter.com/hijicho/ ( ) Hijicho http://hijicho.comhttp://twitter.com/hijicho/

More information

2

2 1 2 3 1) 2) 3) 2 3 1 2 3 4 5 6 7 8 9 10 11 4 12 13 14 15 X 16 X 17 X CT 18 MRI 19 20 4 A. ENG T&T B. ABLB SISI ABR ASSRMLRSRL 5 5 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 6 1 2 3 4 7 1 POS( Problem

More information

CD PAC CKD M RT AI TPP K orotkoff K orotkoff O VT O VT DIC AIDS RS RS RS AH3 A10 A16 RS B ordetella pertussis O 111 O111H VT12 O121H 19 VT2 O 20H 6 eae O55H 7 eae O 145H UT eae Salm onella O7r5

More information

E-mail rsakurai@jade.dti.ne.jp 2000. 2. 1-1-

E-mail rsakurai@jade.dti.ne.jp 2000. 2. 1-1- E-mail rsakurai@jade.dti.ne.jp 2000. 2. 1-1- LD LD LD -2- MBD Minimal Brain Dysfunction Syndrome -3- Minimal Brain Dysfunction Syndrome : --- WISC-WPPSIK-ABC --- CTMRIEEG --- 40 60-4- -5- MBD MBD MBD MBD

More information

10K1A NASA () SPACE ATLAS Freedom H2A NASA 1

10K1A NASA () SPACE ATLAS Freedom H2A NASA 1 10O1A 10 10 1 10K1A NASA () SPACE ATLAS 40 1957 1969 10 1986 1990 Freedom 20 000 H2A NASA 1 10K1A 100 10 21 40 1996 ( 200 () 2 10S1A 10 8 57 250 1 10S1A 20 200mmm 2 10S1B 18 18 1 10S1B 40 10 20 2 10S1C

More information

20●12頁●6-14▲放射線科▲.ppt

20●12頁●6-14▲放射線科▲.ppt No.268 Katayama H. et al. Adverse reactions to ionic and nonionic contrast media-a report from the Japanese Committee of the Safety of Contrast Media. Radiology 1990;175:621-628. 12.66% 3.13% 0.22% 0.04%

More information

1 2 3 4 5 6 7 9 14 10 10 27 11 12 LINE 13 3 14 15 16 17 ADHD 18 IQ 19 20 21 22 23 24 25 26 27 28 29 4 30 31 32 ADHD DVD 1 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 http://www.edu.city.kyoto.jp/seitoshido/

More information

007-228.indb

007-228.indb 2010 135 1. 2003 2004 1 2 136 2. 1 2 KBS 2002 2003 6 NHK 10 NHK BS 20.6 2005 9 2 3 2 10 2 2 2 2 137 3. 20 40 50 2 20 14 40 50 19 a b c d e a b DVD c DVD d a b c d e a b c d e a b c d a b c d e a b a b

More information

DCR-PC300K/IPK

DCR-PC300K/IPK 3-084-945-02(1) 6 19 31 34 39 2003 Sony Corporation * b 2 3 6 19 31 4 34 39 5 \ 6 * * * 7 1 2 * 3 b 4 1 2 5 6 8 7 1 8 1 2 *, 9 2 7 3 8 * 4 9 5 6 z 10 10 1 2 3 1 1 11 2 * 2, 11 3 8 4 5 9 6 7 12 13 b,,,,,

More information

地域主権改革と東京一極集中

地域主権改革と東京一極集中 2011.6.18 1 2 3 4 5 6 21 北 21 7 8 21 246 9 1985 1990 1995 2000 2005 2010 401,352 396,554 393,885 386,551 375,591 369,400 252/3 1985 1990 1995 2000 2005 2010 4,581 3,928 3,739 3,912 2,943 3,064 1,912 405

More information

NEDO

NEDO 10 MRI 1 1 595% 5 IOR 100% MRI MRI MRI MRI MRI MRI 11 MRI 3 2 1 MRI 1 1.5 0.000005 100 5 MRI MRI MRI MRI MRI MRI MRI MRI MRI (1) MRI MRI 0.3 3 MRI 1 / (2) MRI MRI (3)MRI MRI 3 (4)MRI MRI MRI (5)MRI 2006

More information

資料2-3 現行学習指導要領における情報に関する主な記述

資料2-3 現行学習指導要領における情報に関する主な記述 4 9 3 1 22 A B C 3 4 1 3 3 4 342C 3 4 C 1 562B 5 6 B 1 3 1 3 5 2 5 4 5 3 54 3 22 5 3 22 1 4 B1 6 B4 1 2 3 4 5 6 2 A1 2 B2 3 3 22 3 5 6 5 6 2 B 1 5 6 B 5 6 1 1 5 6 2 D 1 D 3 5 3 52 3 1 6CDDVD CDDVD 22 2

More information

天草郡市医師会第139回(臨時)代議員会

天草郡市医師会第139回(臨時)代議員会 A 97 2(B A2) 4(A B3) 2 95 B 104 25(A B3) 16(B A2) 9 113 201 27 20 7 208 2 1 13 3 18 4 19 3 3 2 2 13 4 17 3 18 6 26 6 30 17 18 17 17 17 17 18 ( ) 18 ( ) 18 ( ) 18 ( ) 18 ( ) ( ) ( ) ( ) ( ) ( ) 18 ( ) (

More information

untitled

untitled ~ ~ ~ ~ ~ 22 14 10 50cm 2124 15 21 29.5 11, 12 12 20 4040 10 60 60 10 20 20 11 ç ç çç 6070 ç ç çç p. ç çç 4.5cm2.5cm 25 http://www.crdc.gifu-u.ac.jp/edsoftol/water/

More information

シンポジウム 報告書_5.PDF

シンポジウム 報告書_5.PDF ... 2... 2... 2... 2... 2... 3... 3... 4... 6... 6... 6... 10... 10... 13... 13... 15... 17... 18... 21... 22 23... 23... 23... 24... 28... 30... 32 1 2 2 30 3 4 5 6 biodiversity 7 4 8 9 TV 10 NHK 11 12

More information

PJ NPO 3 28 NPO3

PJ NPO 3 28 NPO3 NPO 4 2 12 10 PJ NPO 3 28 NPO3 21 32 31 21 1950 9.3 19.7 6.5 75.3 42.8 8.9 5.8 9.2 25.4 8000 3 6 WhatHow Why 125 NIH 1 3000 5000 100 1 2 0.5 1 5 5 1 VC VC 1 20 1,000 1,000 VC 216 437 19 37 34

More information

untitled

untitled -1 - 72 DVD 34-2 - 49-3 - 45-4 - OIE BSE 56 OIE BSE 39 BSE 71-5 - 20 30 69-6 - 66-7 - 28-8 - 1 43-9 - 38-10 - 58 46-11 - 69 49 48-12 - 43-13 - 76 35-14 - 43 2 37 2 65 68 CM 57-15 - 19 73 70-16 - - 17 -

More information

CW3_AX056A01.indd

CW3_AX056A01.indd 165 166 167 168 169 170 A 171 172 173 174 175 176 177 178 179 ritalin http://www.ncnp.go.jp/nimh/yakubutsu/drug-top/data/ researchjhs.pdf 180 mg mg http://www.novartis.co.jp/product/rit/te/te_rit. html

More information

( ) ( ) ( ) D VD

( ) ( ) ( ) D VD DVD ( ) ( ) (FAX ) DVD DVD ( http://www.chibakenshakyo.com) 9:001700 (12:0013:00 ) 260-8508 4 3 1F TEL043-204-6010 FAX043-204-6015 ( ) ( ) ( ) D VD 001XX 3 18 VHS 3 XX 2 : CS 1 6 10 13 15 18 21 ( ) 27

More information

甲状腺疾患2.PDF

甲状腺疾患2.PDF Vol.14,No1,2005 74 Jan.2005 Vol.14 No.1 Vol.14,No.1,2005 75 Vol.14,No1,2005 76 37.5 TSH TSH TRAb TRAb TSH Vol.14,No.1,2005 77 Vol.14,No1,2005 78 Vol.14,No.1,2005 79 T4 T3 16) S Vol.14,No1,2005 80 1 1.

More information

-2-

-2- Super Lizer HT-2200 m m W Super Lizer -1- -2- -3- -4- stellate ganglion block stellate ganglion -5- -6- -7- -8- IgA -9- " " -10- -11- 5 6 10 1-12- -1- -2- mv -3- -4- -5- -1- : -2- No.2576 P.25 1973-3-

More information

1 2 3 4 5 68g 9g 2g 0.2mg 0.8mg 316kcal 316cal 326kcal 326cal 6 010 3035 15 5355 30 120 20 7 8 9 10 11 () () () 12 1 3 1 5 1 80kcal 20 30 20 30 1 9 7.5 13 7.58.5 910.5 1213.5 11.512.5 14 15 79 23 1520

More information

1 1 1. 19800 2. 2 1. 2. ( ) ( ) 3 1. ( ) ( ) 60 ( ) ( ) 2. ( ) ( ) ( ) ( ) 4 1. 2. 2/32

1 1 1. 19800 2. 2 1. 2. ( ) ( ) 3 1. ( ) ( ) 60 ( ) ( ) 2. ( ) ( ) ( ) ( ) 4 1. 2. 2/32 1 1 1. 19800 2. 2 1. 2. ( ) ( ) 3 1. ( ) ( ) 60 ( ) ( ) 2. ( ) ( ) ( ) ( ) 4 1. 2. 2/32 3. 5 1. 6 1. 2. 3. 7 1. 30 3 20 2. 100 8 1. 2. 100 3. 100 9 1. 10 1. setuzei_gaido@mail.goo.ne.jp 3/32 4/32 5/32

More information

001-007 扉・口絵・目次

001-007 扉・口絵・目次 1 6 6 7 1 a a a a 2 a a a 3 4 5 a 6 7 8 9 10 a 11 a a a 12 13 14 15 a 16 17 18 19 20 21 22 23 24 b b 25 b 26 27 aa 28 r r 29 a s d f 30 b b 31 32 33 1 34 35 36 37 38 6 39 6 40 41 42 43 44 45 7 47 48

More information

スライド 1

スライド 1 360 350 450 360 130500 350 150 450 25 Fedex( ) CO 500106 130km/h 12 31 31 1 000 7:26 9:58 10:09 18:0311:17 11:49 () () () () ( ) ( ) JR JR (1) (2) (3) 3 15 2009 2230 2343 2344

More information

BAANs理論に基づく保健指導プログラム暫定版

BAANs理論に基づく保健指導プログラム暫定版 WHO 4 5 10% L- -3 RNA L - 1960-3 RNA mrna Bio Activating Advanced Nutrients BAANs BAANs BAANs BAANs L- (NO) -3 EPA, DHA) RNA RNA DNA TNF- PAI-1 ( ) BAANs 40 50% 20% 1Kg 7,000Kcal 50Kcal 11 50Kcal

More information

untitled

untitled 19 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15 19 19 1 17,676 20.0 2 20,970 24.1 3 4,967 23.2 104,10919 4 8,234 18.0 11,428 22.4 1 0 10,954244 17,107 18.7 136 4.8 12,653205 1,239 13.2 10,056686 27,305514

More information

全集’.PDF

全集’.PDF 1 2 3 4 STEP1 STEP2 PC 5 PC http://www.geocities.co.jp/heartland-icho/1493/yumearuki.htm 6 7 8 NO N N N [ ] [ ] [ ] [ ] [ ] [ ] 1 2 N 34 13 1 3 2 1 3 2 9 2 [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] 4 10 NO [ ] [

More information

22

22 2015 75 7074 6569 2064 26470 21 22 4,060 1,330 23 24 15,000 80 24,600 15,000 15,000 24,600 15,000 24,600 15,000 24,600 37,200 145 520 383 44,400 25 26 280 160280 280 346 160 80 160 37,200 24,600 15,000

More information

untitled

untitled Metabolic syndrome,,,, 81 81 , 17 17 2 Lung Ca non small cell carcinoma / / food( food( ) drug( drug( ) 100mg 750mg WBC 5510/ l RBC 483 / l Hb 10.3g/dl, Ht 42.0% Plt 19.0 / l TP 8.1g/dl Alb 4.6g/dl Glb

More information

untitled

untitled 1 http://ac-intelligence.jp/university/index.html PR SPI http://blog.mag2.com/m/log/0000153671/ HP http://ac-intelligence.jp/ minoru@ac-intelligence.jp 2 2007 3 4.1 4.1 410 3 1992 10 20 40 40 15 4 5 1

More information

<5461726F31322D8ED089EF8BB388E7977096DA985E82DC82C682DF2E6A7464>

<5461726F31322D8ED089EF8BB388E7977096DA985E82DC82C682DF2E6A7464> -1- -2- -3- -4- -5- -6- -7- -8- -9- -10- -11- -12- -13- -14- -15- -16- -17- -18- -19- -20- -21- -22- -23- -24- -25- -26- -27- -28- -29- -30- -31- -32- -33- -34- -35- -36- -37- -38- -39- -40- -41- -42-

More information